Mirae Asset Global Investments
BEAM icon

Mirae Asset Global Investments’s Beam Therapeutics BEAM Stock Holding History

Mirae Asset Global Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
4,601
-712
-13% -$21.5K ﹤0.01% 1154
2026
Q1 		$127K Buy
5,313
+382
+8% +$10.6K ﹤0.01% 1145
2025
Q4 		$137K Buy
4,931
+1,020
+26% +$26K ﹤0.01% 1205
2025
Q3 		$94.9K Buy
3,911
+27
+0.7% +$537 ﹤0.01% 1224
2025
Q2 		$66.1K Buy
3,884
+1,175
+43% +$20.5K ﹤0.01% 1219
2025
Q1 		$60.2K Sell
2,709
-50
-2% -$1.31K ﹤0.01% 1209
2024
Q4 		$73.4K Sell
2,759
-222
-7% -$5.67K ﹤0.01% 1199
2024
Q3 		$74.7K Buy
2,981
+524
+21% +$13.5K ﹤0.01% 1234
2024
Q2 		$58.9K Sell
2,457
-221,472
-99% -$5.44M ﹤0.01% 1214
2024
Q1 		$6.78M Buy
223,929
+57,554
+35% +$1.79M 0.01% 800
2023
Q4 		$4.53M Sell
166,375
-159,307
-49% -$3.96M 0.01% 922
2023
Q3 		$7.83M Buy
325,682
+30,909
+10% +$829K 0.02% 714
2023
Q2 		$9.41M Buy
294,773
+67,819
+30% +$2.2M 0.02% 676
2023
Q1 		$6.95M Buy
226,954
+10,469
+5% +$413K 0.02% 771
2022
Q4 		$8.47M Sell
216,485
-29,879
-12% -$1.34M 0.02% 662
2022
Q3 		$11.7M Buy
246,364
+33,357
+16% +$1.9M 0.03% 522
2022
Q2 		$8.24M Buy
+213,007
New +$8.47M 0.02% 671

Other funds holding BEAM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's BEAM Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Beam Therapeutics (BEAM) stake by 13% in Q2 2026, selling an estimated $21.5K and leaving 4,601 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Mirae Asset Global Investments first reported a position in BEAM in Q2 2022 and has held it in 17 quarters since. The position peaked at $11.7M in Q3 2022. 105 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Mirae Asset Global Investments held 4,601 shares of Beam Therapeutics worth $158K as of Q2 2026.
  • Mirae Asset Global Investments sold 712 Beam Therapeutics shares in Q2 2026, an estimated $21.5K.
  • Beam Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1154 holding.
  • Mirae Asset Global Investments first reported a position in Beam Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Beam Therapeutics position peaked at $11.7M in Q3 2022.
  • 105 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.